Global pharmaceutical company Merz Aesthetics has launched Belotero Revive, an injectable resorbable implant indicated for the revitalisation of early onset photodamaged skin.

The company explains that the implant uses patented cohesive polydensified matrix technology which allows for homogeneous dermal integration. The company states that the implant also includes the addition of 17.5mg/ml of glycerol, which has highly hydrophilic properties. According to Merz, this aims to treat the early signs of sun damage by rehydrating the skin, improving elasticity and firmness, and smoothing superficial fine lines.

Marketing manager, Louise Miller, commented, “At Merz Aesthetics, research, development and innovation is at the heart of everything we do, which is why we are so excited to announce a new product launch within our Belotero portfolio. Belotero Revive is a really important addition to our range and will allow healthcare professionals to revitalise and hydrate their patients’ skin. The team at Merz Aesthetics are ready and waiting to take enquiries!”

The product will be available from May 10. 

SOURCEAesthetics Journal
Previous articleAbbVie’s Allergan Aesthetics dishes out $550M for Soliton and its cellulite, tattoo remover
Next articleRealSelf Expands Its Reach with YNS Group Acquisition